Meyer G, Berebbi M, Oth D
Bull Cancer. 1976 Jan-Mar;63(1):111-21.
The authors outline schematically the major histocompatibility complex as well as the relationship between tumor neo-antigen and pre-existing antigens at the cell surface. They note that these two antigenic systems are not independent and in particular, the major histocompatibility system (H-2) co-segregates with the tumour antigens. Considering the complexity of the H=2 system (a H-2 allele does not correspond to any single transplantation antigen but to a combination of several antigens units simultaneously present), the authors recall Boyse's hypothesis, revised by Haywood and Mc Khann, which propose that tumour antigens are a rearrangement of H-2 substructures. Moreover, it is possible that the relationship between H-2 and resistance to cancer may be attributed directly to the action of genes controlling the immune response (Ir region) which could also intervene in recognition of these tumour antigens. Finally, recent results obtained seem to show that some tumour antigens cross-react with H-2 fractions. This fact prevents the mice bearing these types of alleles from being immunized against the cross-reacting tumours. If this result could be transposed to the human situation, it would explain the frequency of certain types of tumours in defined H-LA groups and could allow the prediction of high-risk groups.
作者简要概述了主要组织相容性复合体以及肿瘤新抗原与细胞表面预先存在的抗原之间的关系。他们指出,这两种抗原系统并非相互独立,特别是主要组织相容性系统(H-2)与肿瘤抗原共同分离。考虑到H-2系统的复杂性(一个H-2等位基因并不对应任何单一的移植抗原,而是对应同时存在的几种抗原单位的组合),作者回顾了由海伍德和麦肯修订的博伊斯假说,该假说提出肿瘤抗原是H-2亚结构的重排。此外,H-2与抗癌抗性之间的关系可能直接归因于控制免疫反应的基因(Ir区域)的作用,这些基因也可能参与对这些肿瘤抗原的识别。最后,最近获得的结果似乎表明,一些肿瘤抗原与H-2片段发生交叉反应。这一事实使得携带这些等位基因类型的小鼠无法针对交叉反应性肿瘤进行免疫。如果这一结果能够应用于人类情况,那么它将解释特定H-LA组中某些类型肿瘤的发生频率,并能够预测高危人群。